Skip to content

Braveheart Bio

US · BRVE #2845 by market cap Listed 2026
20.39 +1.12 +5.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Revenue annual, last 1 years

Income statement

Line item 2025
Revenue --
Gross profit --
Selling & admin expenses 3.02M
Research & development 63.73M
Operating profit -66.75M
Pretax profit -66.05M
Tax --
Net profit -66.05M
Basic EPS -5
Diluted EPS -5.32

Balance sheet

Line item 2025
Total current assets 89.28M
Cash & ST investments 89.16M
Inventory --
Total assets 89.35M
Total current liabilities 5.24M
Short-term debt --
Long-term debt --
Total liabilities 5,333,000.00
Total equity 84.02M
Retained earnings -66.05M

Cash flow

Line item 2025
Operating cash flow -2.01M
Depreciation & amortization --
Free cash flow -35.58M
Dividends paid --
Stock buybacks / issuance 95.00K
Ending cash balance 89.16M

Returns & efficiency

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Braveheart Bio discussion 0 comments

Add a comment